Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Operating Margin: 2009-2024

Historic Operating Margin for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to 14.88%.

  • OptimizeRx's Operating Margin rose 480400.0% to 7.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.17%, marking a year-over-year increase of 382000.0%. This contributed to the annual value of 14.88% for FY2024, which is 220400.0% up from last year.
  • According to the latest figures from FY2024, OptimizeRx's Operating Margin is 14.88%, which was up 220400.0% from 36.91% recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Operating Margin peaked at 0.59% during FY2021, and registered a low of 36.91% during FY2023.
  • Over the past 5 years, OptimizeRx's median Operating Margin value was 14.88% (recorded in 2024), while the average stood at 15.16%.
  • As far as peak fluctuations go, OptimizeRx's Operating Margin crashed by -202700bps in 2022, and later soared by 220400bps in 2024.
  • OptimizeRx's Operating Margin (Annual) stood at 4.93% in 2020, then skyrocketed by 112bps to 0.59% in 2021, then tumbled by -3441bps to 19.68% in 2022, then crashed by -88bps to 36.91% in 2023, then soared by 60bps to 14.88% in 2024.
  • Its Operating Margin was 14.88% in FY2024, compared to 36.91% in FY2023 and 19.68% in FY2022.